Interim Report for 1 January - 30 September 2013 COMPANY

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Interim Report for 1 January - 30 September 2013

COMPANY ANNOUNCEMENT No 56/2013 – 21 November 2013

Growth reinforces Royal Unibrew’s market positions and results

Net revenue for the nine months to 30 September 2013 increased by 14%, whereas sales volumes increased by 17%. In organic terms, net revenue and sales volumes went up by 10% and 11%, respectively. As expected, the highest growth was achieved in the malt beverages segment showing double-digit organic volume and net revenue growth, but also the North East Europe segment saw double-digit organic volume and net revenue growth (excluding the Hartwall acquisition).

Earnings before interest, tax, depreciation and amortisation (EBITDA) amounted to DKK 545 million (2012: DKK 490 million) and was positively affected by DKK 27 million from Hartwall. Earnings before interest and tax (EBIT) for the nine months to 30 September 2013 amounted to DKK 449 million – a DKK 49 million increase on last year, including DKK 9 million relating to Hartwall. Moreover, results were positively affected by really good summer weather and high supply chain efficiency. EBIT margin decreased by 30 bp to 14.7%. Organically, EBIT margin went up by 20 bp.

Based on the results achieved for the year to 30 September 2013, Royal Unibrew now expects net revenue of DKK 4,340-4,425 million, EBITDA of DKK 695-735 million and EBIT of DKK 510-550 million for 2013.

”The really good summer and our continued focus on and investment in commercial activities had a positive effect on our sales and market shares – in spite of continued consumer restraint. Combined with high supply chain efficiency, this contributed towards a positive earnings development. Our malt beverages business saw the highest growth as a result of our focus on this area. But also the Baltic countries experienced a high growth rate, and consumers responded favourably to both our new beer and soft drinks products. In the Danish market, the Royal Beer and Faxe Kondi brands continue showing progress and contribute significantly to reinforcing Royal Unibrew’s overall market position. In Finland we acquired Hartwall at the end of August, and integration is proceeding as planned”, says Henrik Brandt, CEO.

HIGHLIGHTS

  • Royal Unibrew has generally increased its market shares for branded beer as well as soft drinks and malt beverages.
  • Net revenue for Q3 increased by 35% and for the nine months to 30 September 2013 by 14%. Organically (adjusted for the Hartwall acquisition and the divestment of Impec in 2012), net revenue for Q3 went up by 15% and for YTD by 10%.
  • EBITDA for Q3 amounted to DKK 268 million compared to DKK 212 million in 2012 and for the nine months to 30 September 2013 to DKK 545 million compared to DKK 490 million. Organically, EBITDA went up by DKK 33 million YTD 2013.
  • Earnings before interest and tax (EBIT) for Q3 went up by DKK 40 million to DKK 224 million and for the nine months to 30 September by DKK 49 million to DKK 449 million. Organically, EBIT went up by DKK 45 million YTD 2013. EBIT margin for the nine months to 30 September decreased by 30 bp to 14.7%. Organically, it went up by 20 bp.
  • Profit before tax for the nine months to 30 September amounted to DKK 447 million compared to DKK 397 million in 2012.
  • Free cash flow for Q3 was DKK 129 million below the 2012 figure and amounted to DKK 151 million. Free cash flow for the nine months to 30 September 2013 amounted to DKK 357 million compared to DKK 551 million in 2012.

OUTLOOK

The results realised YTD reflect, among other things, the really good summer weather, market shares assessed to be temporarily high, better sales in Italy than expected and high supply chain efficiency. On this basis, the outlook in terms of net revenue, EBITDA and EBIT for the year is adjusted, after which the outlook for 2013 before integration costs related to Hartwall is as follows:

Incl. Hartwall from 23 August 2013   Current outlook 2013* Outlook 2013 previously announced* Actual 2012  excluding Impec
Net revenue (mDKK)   4,340-4,425 4,065-4,225 3,330
EBITDA (mDKK)   695-735 655-720 605
EBIT (mDKK)   510-550 460-525 480

*Hartwall will unchanged be included with an expected net revenue of DKK 740-775 million, EBITDA of DKK 80-95 million and EBIT of DKK 10-25 million before integration costs but including transaction costs of approx DKK 15 million and amortisation of acquired intangible assets of DKK 10 million in 2013. Before extraordinary items and on a full-year basis, Hartwall is expected to realise net revenue at the level of DKK 2.3 billion and EBITDA at the level of DKK 350-370 million, whereas EBIT is expected to be at the level of DKK 200-220 million (excluding amortisation of acquired intangible assets) for 2013.

For further information on this Announcement:Henrik Brandt, CEO, tel +45 56 77 15 13

It will be possible for investors and analysts to follow Royal Unibrew’s presentation of the Interim Report on Thursday, 21 November 2013, at 9.00 am by audiocast at one of the following dial-in numbers:

Danish participants dial: + 45 327 280 18 US participants dial: + 1 866 682 8490 International number: + 44 (0) 1452 555131.

The presentation may also be followed at Royal Unibrew’s website www.royalunibrew.com.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 3

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 6

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading
AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Updated Category News Views 5

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

Continue Reading
Chicago Scenic Studios’ Equipment Up for Grabs in Auction

Updated Category News Views 8

A Peek into the Sale: What's on the Block? Get that coffee brewing and settle in, because we've got to unpack some interesting stuff happening with Chicago Scenic Studios. This isn't just any Craigslist decampment—Integra Asset Solutions is rolling out an online auction come October 27 that’ll have equipment-savvy investors’ ears perking up like they just snagged a...

Continue Reading
Ama La Vida's New Coaching: More Than a Financial Plan

Updated Category News Views 1

Breaking the Retirement Myth Retirement ain't just about sailing off into the sunset with a fat wallet. What happens when the honeymoon period of the "golden years" ends and you're left pacing the floorboards, unsure of what comes next? Enter Ama La Vida's fresh approach to retirement coaching, tackling the side of retirement that's rarely spoken about: identity,...

Continue Reading
New Chapter Recovery Garners Key Accreditations

Updated Category News Views 4

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

Continue Reading
Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Updated Category News Views 5

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

Continue Reading
Dickinson Brands Celebrates Witch Hazel Legacy with Event

Updated Category News Views 6

Witch Hazel's Timeless Appeal You don’t get to celebrate over one and a half centuries of a product without doing something right. Dickinson Brands Inc. is throwing a bash worth noticing as they mark the sixth annual National Witch Hazel Day on October 21st. It’s a head-nod to the versatile witch hazel, a product that’s been part of New England's heritage since the...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 8

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
Nomada Fund Launches: A Game-Changer in New Media

Updated Category News Views 6

Changing the Investment Game In a world where tech isn't the only kingmaker, distribution is the new play. Welcome the Nomada Fund, a fresh face on the investment scene that's swapping cash for exposure. Forget the traditional media-for-equity model that only old-timers still drool over—these guys are taking it up a notch with their new Distribution for Equity approach,...

Continue Reading

Top 5 Most Recently Viewed Articles

Highland Opportunities and Income Fund Unveils Monthly Payout Plans

Updated Category News Views 288

Highland Opportunities and Income Fund Announces Monthly Distribution The Highland Opportunities and Income Fund (NYSE: HFRO) has made an exciting announcement for its investors. The Fund is set to distribute $0.0385 per share for its common stock. This regular monthly distribution showcases the commitment of HFRO to return value to its shareholders. Understanding the...

Continue Reading
Invivyd Showcases PEMGARDA™ Advances at IDWeek 2024

Updated Category News Views 330

Invivyd Outlines Significant Findings on PEMGARDA™ at IDWeek 2024 Invivyd, Inc. (Nasdaq: IVVD), a dedicated biopharmaceutical enterprise, is set to present groundbreaking findings related to its investigational monoclonal antibody, pemivibart, at the much-anticipated IDWeek 2024 conference. Here, researchers and healthcare professionals will gather in Los Angeles to...

Continue Reading
AI's Impact on Software Engineering: Skills and Challenges Ahead

Updated Category News Views 249

AI's Remarkable Transformation of Software Engineering The world of software engineering is undergoing a significant transformation thanks to artificial intelligence (AI), redefining the roles engineers play and the skills necessary for success. A recent survey highlights that as AI continues to integrate into engineering practices, the fundamental aspects of this...

Continue Reading
Record Participation at the 5th Future Minerals Forum Examined

Updated Category News Views 108

5th Future Minerals Forum Successfully Concludes The recent edition of the Future Minerals Forum achieved impressive milestones with a remarkable attendance of 21,500 participants. This event marked a significant convergence of industry leaders, including investment executives, mining company heads, and experts from various technical fields around the globe. Key Agreement...

Continue Reading
Floreo's New Scientific Advisory Board Champions VR Therapy

Updated Category News Views 254

Floreo's New Scientific Advisory Board Champions VR Therapy Floreo, a trailblazer in virtual reality (VR) therapy for neurodivergent individuals, proudly announces the formation of its inaugural scientific advisory board. The board will consist of six distinguished leaders from the realms of behavioral health research, clinical practice, and healthcare delivery, enhancing...

Continue Reading